A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease
Public ClinicalTrials.gov record NCT04536688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
Study identification
- NCT ID
- NCT04536688
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Regulus Therapeutics Inc.
- Industry
- Enrollment
- 19 participants
Conditions and interventions
Interventions
- RGLS4326 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2020
- Primary completion
- Nov 11, 2021
- Completion
- Nov 11, 2021
- Last update posted
- Dec 14, 2021
2020 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Balboa Nephrology Medical Group | La Mesa | California | 91942 | — |
| Academic Medical Research Institute | Los Angeles | California | 90022 | — |
| Yale Nephrology Clinical Research | New Haven | Connecticut | 06510 | — |
| Accel Research Sites- Mid-Florida Kidney and Hypertension Care | Altamonte Springs | Florida | 32701 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| St. Clair Nephrology Research | Roseville | Michigan | 48066 | — |
| Mayo Clinic | Rochester | Minnesota | 55904 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| ICON Early Phase Services | San Antonio | Texas | 78209 | — |
| Swedish Polycystic Kidney Disease Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04536688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04536688 live on ClinicalTrials.gov.